Literature DB >> 32339403

Supra-coronary aortic banding improves right ventricular function in experimental pulmonary arterial hypertension in rats by increasing systolic right coronary artery perfusion.

Lian Tian1, Ping Yu Xiong1,2, Elahe Alizadeh3, Patricia D A Lima3, François Potus1, Jeffrey Mewburn1, Ashley Martin1, Kuang-Hueih Chen1, Stephen L Archer1,3.   

Abstract

AIM: Pulmonary arterial hypertension (PAH) results in right ventricular (RV) dysfunction owing, in part, to RV ischemia. The relative contribution of RV microvascular rarefaction vs reduced right coronary artery perfusion pressure (RCA-PP) to RV ischemia remains unknown. We hypothesize that increasing RCA-PP improves RV function in PAH by increasing RV systolic perfusion.
METHODS: Supra-coronary aortic banding (SAB) or sham surgery was performed on male Sprague-Dawley rats. Seven to ten days later, rats received either monocrotaline (MCT; 60 mg/kg) or saline. After 1 month, echocardiography, cardiac catheterization, 99m Tc-sestamibi single-photon emission computed tomography (SPECT) and microsphere infusion studies were performed. The RV was harvested for measurement of hypertrophy (RVH), fibrosis and immunoblotting, and the lung was harvested for pulmonary artery (PA) histology.
RESULTS: Supra-coronary aortic banding increased systolic pressures in proximal aorta and systolic RCA-PP in SAB + MCT vs MCT rats (114 ± 12 vs 5 ± 9 mm Hg), without altering diastolic RCA-PP. SAB + MCT rats had improved RV function vs MCT rats, evident from their significantly increased cardiac output (CO), RV free wall (RVFW) thickening, tricuspid annular plane systolic excursion (TAPSE) and RV-PA coupling indices. RV-PA coupling indices and CO correlated directly with systolic RCA-PP. RV perfusion was increased in SAB + MCT vs MCT rats and correlated well with CO; whereas microvascular rarefaction was unaltered. SAB + MCT rats had less RVH and fibrosis and lower PA pressures vs MCT rats. SAB + MCT rats had significantly lower RV pyruvate kinase muscle isoform 2/1 ratios than MCT rats, consistent with restoration of oxidative metabolism.
CONCLUSION: A SAB-induced increase in systolic RCA-PP improves RV perfusion and function in MCT rats. Maintaining systolic RCA perfusion can preserve RV function in PAH.
© 2020 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  coronary artery; microvascular rarefaction; mitochondrial metabolism; monocrotaline; pyruvate dehydrogenase kinase; single-photon emission computed tomography (SPECT)

Mesh:

Year:  2020        PMID: 32339403      PMCID: PMC7363583          DOI: 10.1111/apha.13483

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  39 in total

Review 1.  The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.

Authors:  John J Ryan; Stephen L Archer
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

Review 2.  Emerging role of angiogenesis in adaptive and maladaptive right ventricular remodeling in pulmonary hypertension.

Authors:  Andrea L Frump; Sébastien Bonnet; Vinicio A de Jesus Perez; Tim Lahm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-11-02       Impact factor: 5.464

3.  MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.

Authors:  Zhigang Hong; Kuang-Hueih Chen; Asish DasGupta; Francois Potus; Kimberly Dunham-Snary; Sebastien Bonnet; Lian Tian; Jennifer Fu; Sandra Breuils-Bonnet; Steeve Provencher; Danchen Wu; Jeffrey Mewburn; Mark L Ormiston; Stephen L Archer
Journal:  Am J Respir Crit Care Med       Date:  2017-02-15       Impact factor: 21.405

Review 4.  Pulmonary arterial hypertension: challenges in translational research and a vision for change.

Authors:  Gopinath Sutendra; Evangelos D Michelakis
Journal:  Sci Transl Med       Date:  2013-10-23       Impact factor: 17.956

5.  Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

Authors:  G E D'Alonzo; R J Barst; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; J T Kernis
Journal:  Ann Intern Med       Date:  1991-09-01       Impact factor: 25.391

6.  Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.

Authors:  Hui Zhang; Daren Wang; Min Li; Lydie Plecitá-Hlavatá; Angelo D'Alessandro; Jan Tauber; Suzette Riddle; Sushil Kumar; Amanda Flockton; B Alexandre McKeon; Maria G Frid; Julie A Reisz; Paola Caruso; Karim C El Kasmi; Petr Ježek; Nicholas W Morrell; Cheng-Jun Hu; Kurt R Stenmark
Journal:  Circulation       Date:  2017-09-26       Impact factor: 29.690

Review 7.  Right Ventricular Perfusion: Physiology and Clinical Implications.

Authors:  George J Crystal; Paul S Pagel
Journal:  Anesthesiology       Date:  2018-01       Impact factor: 7.892

8.  Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension.

Authors:  Adam Torbicki; Marcin Kurzyna; Paweł Kuca; Anna Fijałkowska; Jarosław Sikora; Michał Florczyk; Piotr Pruszczyk; Janusz Burakowski; Lilianna Wawrzyńska
Journal:  Circulation       Date:  2003-08-04       Impact factor: 29.690

9.  Biventricular Increases in Mitochondrial Fission Mediator (MiD51) and Proglycolytic Pyruvate Kinase (PKM2) Isoform in Experimental Group 2 Pulmonary Hypertension-Novel Mitochondrial Abnormalities.

Authors:  Ping Yu Xiong; Lian Tian; Kimberly J Dunham-Snary; Kuang-Hueih Chen; Jeffrey D Mewburn; Monica Neuber-Hess; Ashley Martin; Asish Dasgupta; Francois Potus; Stephen L Archer
Journal:  Front Cardiovasc Med       Date:  2019-01-25

10.  Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension.

Authors:  Stephen L Archer; Yong-Hu Fang; John J Ryan; Lin Piao
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

View more
  3 in total

1.  Inhibiting pyruvate kinase muscle isoform 2 regresses group 2 pulmonary hypertension induced by supra-coronary aortic banding.

Authors:  Ping Yu Xiong; Mehras Motamed; Kuang-Hueih Chen; Asish Dasgupta; François Potus; Lian Tian; Ashley Martin; Jeffrey Mewburn; Oliver Jones; Arthur Thébaud; Stephen L Archer
Journal:  Acta Physiol (Oxf)       Date:  2022-01-17       Impact factor: 6.311

2.  Chronic Sigma 1 receptor activation alleviates right ventricular dysfunction secondary to pulmonary arterial hypertension.

Authors:  Yazhou Sun; Weiguo Wan; Xin Zhao; Xueyu Han; Tianxin Ye; Xiaoli Chen; Qian Ran; Xiukun Wang; Xin Liu; Chuan Qu; Shaobo Shi; Cui Zhang; Bo Yang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 3.  Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.

Authors:  Sasha Z Prisco; Thenappan Thenappan; Kurt W Prins
Journal:  JACC Basic Transl Sci       Date:  2020-12-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.